EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Fluoroquinolone and Second-Line Injectable Resistance Among Rifampicin- and Isoniazid-Resistant Mycobacterium tuberculosis Clinical Isolates: A Molecular Study from a High-Burden Setting

Rosângela Siqueira Oliveira, Angela Pires Brandao iD, Fabiane Maria de Almeida Ferreira iD, Sonia Maria da Costa, Vera Lucia Maria Silva, Lucilaine Ferrazoli, Erica Chimara, Juliana Maira Watanabe Pinhata iD

Microorganisms · 29.10.2025 · 13 (11) · 2470

DOI: 10.3390/microorganisms13112470 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microorganisms, online erschienen am 29.10.2025. Verfasst von Rosângela Siqueira Oliveira und 7 weiteren Autor:innen. Beteiligte Einrichtung: Núcleo de Tuberculose e Micobacterioses, Centro de Bacteriologia, Instituto Adolfo Lutz (IAL), São Paulo 01246-000, Brazil. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação de Amparo à Pesquisa do Estado de São Paulo.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug-resistant tuberculosis (DR-TB) threatens global TB control. We investigated the prevalence and molecular characteristics of second-line drug resistance among rifampicin (RIF)- and/or isoniazid (INH)-resistant Mycobacterium tuberculosis complex (MTBC) isolates in São Paulo, Brazil, using the MTBDRsl v. 2.0 line-probe assay. MTBC isolates RIF- and/or INH-resistant by GenoType MTBDRplus or phenotypic testing (2019–2021) were subsequently tested by MTBDRsl for fluoroquinolone (FQ) and injectable drugs (capreomycin, amikacin, kanamycin) resistance. Isolates with inferred mutations underwent Sanger sequencing. Of 13,557 isolates, 728 (5.4%) were RIF- and/or INH-resistant (297 INH-R, 235 RIF-R, 196 MDR). Among them, 623 (85.6%) were tested by MTBDRsl; 582 (93.4%) showed no additional resistance, while 41 (6.6%) carried mutations. FQ resistance was detected in 38 isolates (92.7%), mostly in gyrA (n = 35). Three isolates with gyrB mutations were wild-type by sequencing. Two MDR isolates harbored the rrs a1401g mutation, and one also harbored gyrA D94G. Sequencing confirmed resistance in 38 of 41 isolates. Most MDR strains with second-line mutations (n = 32/33; 97%) were pre-XDR. Affected patients were predominantly male (68.4%), with pulmonary TB (92.1%), and unfavorable outcomes (39.5%). Second-line resistance prevalence was low overall, but FQ resistance was high among MDR isolates. Findings support integrating molecular and sequencing-based tools for accurate detection and management of DR-TB.

Schlagwörter

Stichwörter der Autor:innen

gene sequencingline probe assaymultidrug-resistant tuberculosissecond-line anti-tuberculosis drugs

Autor:innen und Institutionen

  • Núcleo de Tuberculose e Micobacterioses, Centro de Bacteriologia, Instituto Adolfo Lutz (IAL), São Paulo 01246-000, Brazil.
  • Instituto Oswaldo Cruz, Fundação Oswaldo Cruz (FIOCRUZ), Rio de Janeiro 21040-360, Brazil.

ORCID-Profile: Angela Pires Brandao, Fabiane Maria de Almeida Ferreira, Juliana Maira Watanabe Pinhata

Förderung

  • Fundação de Amparo à Pesquisa do Estado de São Paulo

Zitieren

APA

Oliveira, R. S., Brandao, A. P., Ferreira, F. M. A., Costa, S. M. D., Silva, V. L. M., Ferrazoli, L., Chimara, E., & Pinhata, J. M. W. (2025). Fluoroquinolone and Second-Line Injectable Resistance Among Rifampicin- and Isoniazid-Resistant Mycobacterium tuberculosis Clinical Isolates: A Molecular Study from a High-Burden Setting. Microorganisms, 13(11), 2470. https://doi.org/10.3390/microorganisms13112470

Vancouver

Oliveira RS, Brandao AP, Ferreira FMA, Costa SMD, Silva VLM, Ferrazoli L, et al. Fluoroquinolone and Second-Line Injectable Resistance Among Rifampicin- and Isoniazid-Resistant Mycobacterium tuberculosis Clinical Isolates: A Molecular Study from a High-Burden Setting. Microorganisms. 2025;13(11):2470. doi:10.3390/microorganisms13112470

BibTeX
@article{Oliveira2025,
  author = {Oliveira, Rosângela Siqueira and Brandao, Angela Pires and Ferreira, Fabiane Maria de Almeida and Costa, Sonia Maria da and Silva, Vera Lucia Maria and Ferrazoli, Lucilaine and Chimara, Erica and Pinhata, Juliana Maira Watanabe},
  title = {Fluoroquinolone and Second-Line Injectable Resistance Among Rifampicin- and Isoniazid-Resistant Mycobacterium tuberculosis Clinical Isolates: A Molecular Study from a High-Burden Setting},
  journal = {Microorganisms},
  year = {2025},
  volume = {13},
  number = {11},
  pages = {2470},
  doi = {10.3390/microorganisms13112470}
}
Kostenlos starten →